Medical device maker Cyberonics, Inc. (NASDAQ:CYBX)’s shares jumped around 13% on Friday following the firm declared fiscal Q2 earnings, increased by a one-time gain, in front of estimates.
Cyberonics generated 44 cents per share, increased 37 percent from the year-earlier quarter. Analysts had anticipated a profit of 39 cents per share.
With Friday’s gain, shares of Cyberonics increased around 52 percent in 2012.
The Houston-based company raised its full-year profit estimate to a range of $1.56 to $1.62 a share, up from its earlier guidance of $1.49 to $1.59 a share.
Cyberonics makes implantable devices that treat epilepsy and other neurological problems.
Cyberonics, Inc. (NASDAQ:CYBX) opened at $48.20 with 27.59 million outstanding shares and touch its highest price of $52.48 of the day and then finished at $52.44 by scoring 12.53%, as in the whole session stocks gain volume of 1.01 million shares which is higher than its average volume.
As the owner ship concerns stock institutional ownership remained 93.99% while insider ownership included 2.95%. The share capital of CYBX has 27.59 million outstanding shares amid them 26.68 million shares have been floated in market.
For investors focus on the performance of the stocks so the CYBX showed weekly ahead performance of 17.84% which was maintained for the month at 2.56%. Correspondingly the positive performance for the quarter was remained 16.84% and if took notice on yearly performance that was 79.84% whereas the year to date performance halted at 56.54%.
As the moving toward the returns measures returns on Investment ratio is significant measure which investor should have in consideration, the CYBX return on investment was recorded as 21.95% as compare to its rivals has Boston Scientific Corporation (NYSE:BSX)’s ROI -23.18%, Medtronic, Inc. (NYSE:MDT)’s ROI 12.88%, St. Jude Medical, Inc. (NYSE:STJ)’s ROI 9.70%, Hologic, Inc. (NASDAQ:HOLX)’s ROI -0.96%.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com